Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy.
1/5 보강
Cancer immunotherapy has transformed treatment but faces challenges such as immune evasion and toxicity.
APA
Jaiswal T, Chhabra G, Ahmad N (2025). Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy.. Trends in cancer, 11(11), 1037-1040. https://doi.org/10.1016/j.trecan.2025.08.003
MLA
Jaiswal T, et al.. "Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy.." Trends in cancer, vol. 11, no. 11, 2025, pp. 1037-1040.
PMID
40885612 ↗
Abstract 한글 요약
Cancer immunotherapy has transformed treatment but faces challenges such as immune evasion and toxicity. Polo-like kinases (PLKs), frequently dysregulated in tumors, are emerging as key immune modulators. Combining PLK inhibition with immunotherapy may overcome resistance, enhance antitumor responses, and improve clinical outcomes, offering an optimally efficient strategy for cancer treatment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.